log
My
Contact
>
Products
>
>
>
Flamma® Fluors Amine
>
Flamma® 648 Amine
- Flamma® Fluors NHS ester
- Flamma® Fluors Sulfo-NHS ester
- Flamma® Fluors Vinylsulfone
- Flamma® Fluors Isothiocyanate
- Flamma® Fluors Maleimide
- Flamma® Fluors Hydrazide
- Flamma® Fluors Dichlorotriazine
- Flamma® Fluors Carboxylic acid
- Flamma® Fluors Amine
- Flamma® Fluors Thiol
- Flamma® Fluors Alkyne
- Flamma® Fluors PEG4-Alkyne
- Flamma® Fluors ADIBO
- Flamma® Fluors Azide
Flamma® 648 Amine
Catalog No. PWE1215
| PACKING UNIT | price |
Lead time |
|---|---|---|
| 1 mg | $121.00 | |
| 5 mg | $420.00 | |
| 25 mg | $840.00 |
Description
Flamma® Fluors 648 Amine is inactive form of far-red fluorescent dye induced from cyanine structure and used to generate a stable fluorescence signal in bioimaging. The primary amine is attached to Flamma 648 through a spacer. The maxima of Ex/Em values are at 648/663 nm, similar to that of Alexa 647, Cy5 and DyLight 650. Flamma 648 might be excited using 593 or 633 nm laser lines and displays excellent optical property. Flamma® Fluors 648 amine can be coupled with carboxylic acids at small molecules or on biomolecules by standard amide bond coupling conditions or can be utilized as a reference standard for dye-conjugates.
Citation & Reference
1. Kim S, Injectable immunogel based on polymerized phenylboronic acid and Mannan for Cancer Immunotherapy. Journal of Controlled Release. 2022 May;345:138–46.
2. Kang B-Y, Phenylboronic acid conjugated to doxorubicin nanocomplexes as an anti-cancer drug delivery system in hepatocellular carcinoma. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 Jun;34:102389.
3. Kim H, Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of covid-19-associated cytokine storm. Nano Today. 2021 Jun;38:101149.
4. Lim J, Phenylboronic-acid-based nanocomplex as a feasible delivery platform of immune checkpoint inhibitor for potent cancer immunotherapy. Journal of Controlled Release. 2021 Feb;330:1168–77.
5. Kim J, Direct fabrication of freestanding and patterned nanoporous junctions in a 3D micro‐nanofluidic device for Ion‐Selective Transport. Small. 2020 Apr 29;16(22).
6. Kim J, Polymer/aptamer-integrated gold nanoconstruct suppresses the inflammatory process by scavenging ROS and capturing pro-inflammatory cytokine TNF-α. ACS Applied Materials & Interfaces. 2020 Nov 6;13(8):9390–401.
7. Jung S, Polymeric nanoparticles controlled by on‐chip self‐assembly enhance cancer treatment effectiveness. Advanced Healthcare Materials. 2020 Oct 18;9(22).
8. Kim J, Direct fabrication of freestanding and patterned nanoporous junctions in a 3D micro‐nanofluidic device for Ion‐Selective Transport. Small. 2020 Apr 29;16(22).
9. Lee SY, Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma. Biomaterials Science. 2019;7(11):4624–35.
10. Son S, Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration. Acta Biomaterialia. 2018 Oct;79:294–305.
11. Kim E, Rapid and versatile cell aggregate formation using lipid-conjugated heparin. ACS Applied Materials & Interfaces. 2018 Jun 28;10(29):24431–9.
12. Jeong JY, Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Acta Biomaterialia. 2017 Apr;53:414–26.
13. Yhee, Ji Young. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. Journal of Controlled Release 198 (2015): 1-9.
14. Oh, Keun Sang. Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate system. International journal of nanomedicine 9 (2014): 2955.
15. Yoon, Hong Yeol. Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA. Scientific reports 4 (2014).
16. Hollis, Christin P. In vivo investigation of hybrid paclitaxel nanocrystals with dual fluorescent probes for cancer theranostics. Pharmaceutical research 31.6 (2014): 1450-1459.
17. Yhee, Ji Young. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice. Bioconjugate chemistry 24.11 (2013): 1850-1860.
18. Yoon, Hong Yeol. Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting. Journal of Controlled Release 172.3 (2013): 653-661.
19. Park, Jin Woo. Wide-Ranged Fluorescent Molecular Weight Size Markers for Electrophoresis. Bulletin of the Korean Chemical Society 34.1 (2013): 29-30.
20. Koo, Heebeom. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials 33.12 (2012): 3485-3493.
21. Zhu, Lei. Real-time monitoring of caspase cascade activation in living cells. Journal of controlled release 163.1 (2012): 55-62.
22. Huang, Xinglu. Multiplex Imaging of an Intracellular Proteolytic Cascade by using a Broad?Spectrum Nanoquencher. Angewandte Chemie International Edition 51.7 (2012): 1625-1630.
23. Ryu, Ju Hee. Early diagnosis of arthritis in mice with collagen?induced arthritis, using a fluorogenic matrix metalloproteinase 3–specific polymeric probe. Arthritis & Rheumatism 63.12 (2011): 3824-3832.
24. Ibrahim, Basma M. A strategy to deliver genes to cystic fibrosis lungs: a battle with environment. Journal of controlled release 155.2 (2011): 289-295.
25. Xu, Peisheng. Zwitterionic chitosan derivatives for pH-sensitive stealth coating. Biomacromolecules 11.9 (2010): 2352-2358.
OPTION
Total
$0
Added cart
We put the items
in the shopping cart.
